Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Biliary Tract Diseases

  Free Subscription


Articles published in J Hepatol

Retrieve available abstracts of 66 articles:
HTML format
Text format



Single Articles


    August 2017
  1. KARLSEN TH, Folseraas T, Thorburn D, Vesterhus M, et al
    Primary sclerosing cholangitis - a comprehensive review.
    J Hepatol. 2017 Aug 9. pii: S0168-8278(17)32196.
    PubMed     Text format     Abstract available


    July 2017
  2. DROGE C, Bonus M, Baumann U, Klindt C, et al
    Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
    J Hepatol. 2017 Jul 18. pii: S0168-8278(17)32147.
    PubMed     Text format     Abstract available


  3. ZHANG S, Song X, Cao D, Xu Z, et al
    Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma induced in mice by AKT and Yap co-expression.
    J Hepatol. 2017 Jul 18. pii: S0168-8278(17)32149.
    PubMed     Text format     Abstract available


  4. FICKERT P, Wagner M
    Biliary bile acids in hepatobiliary injury - What is the link?
    J Hepatol. 2017 Jul 13. pii: S0168-8278(17)32008.
    PubMed     Text format     Abstract available


  5. SCHERBER PR, Lammert F, Glanemann M
    Gallstone disease: Optimal timing of treatment.
    J Hepatol. 2017 Jul 13. pii: S0168-8278(17)30214.
    PubMed     Text format    


  6. TRIVEDI PJ, Scalera I, Slaney E, Laing RW, et al
    Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    J Hepatol. 2017 Jul 6. pii: S0168-8278(17)32135.
    PubMed     Text format     Abstract available


  7. CHAZOUILLERES O
    Norursodeoxycholic acid in patients with primary sclerosing cholangitis: a new "urso saga" in the horizon?
    J Hepatol. 2017 Jul 1. pii: S0168-8278(17)32132.
    PubMed     Text format    


    June 2017
  8. LOOSEN SH, Roderburg C, Kauertz KL, Pombeiro I, et al
    Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma.
    J Hepatol. 2017 Jun 28. pii: S0168-8278(17)32121.
    PubMed     Text format     Abstract available


    May 2017
  9. FICKERT P, Hirschfield GM, Denk G, Marschall HU, et al
    norUrsodeoxycholic Acid Improves Cholestasis in Primary Sclerosing Cholangitis.
    J Hepatol. 2017 May 18. pii: S0168-8278(17)32045.
    PubMed     Text format     Abstract available


    April 2017
  10. GRAMMATIKOPOULOS T, Thompson RJ
    Reply to: Doublecortin domain containing protein 2 (DCDC2) genetic variants in primary sclerosing cholangitis.
    J Hepatol. 2017 Apr 28. pii: S0168-8278(17)30253.
    PubMed     Text format    


  11. CHEUNG AC, Juran BD, Moore RM, LaRusso NF, et al
    Doublecortin domain containing protein 2 (DCDC2) genetic variants in primary sclerosing cholangitis.
    J Hepatol. 2017 Apr 28. pii: S0168-8278(17)30254.
    PubMed     Text format    


  12. HIRSCHFIELD GM, Beuers U, Corpechot C, Invernizzi P, et al
    EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.
    J Hepatol. 2017 Apr 17. pii: S0168-8278(17)30186.
    PubMed     Text format     Abstract available



  13. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline.
    J Hepatol. 2017 Apr 13. pii: S0168-8278(17)30108.
    PubMed     Text format     Abstract available


  14. RIZVI S, Gores GJ
    Emerging Molecular Therapeutic Targets for Cholangiocarcinoma.
    J Hepatol. 2017 Apr 4. pii: S0168-8278(17)30197.
    PubMed     Text format     Abstract available


    March 2017
  15. JULICH-HAERTEL H, Urban SK, Krawczyk M, Willms A, et al
    Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma.
    J Hepatol. 2017 Mar 3. pii: S0168-8278(17)30123.
    PubMed     Text format     Abstract available


    February 2017
  16. ORNTOFT NW, Munk OL, Frisch K, Ott P, et al
    Hepatobiliary transport kinetics of the conjugated bile acid tracer 11C-CSar quantified in healthy humans and patients by Positrion Emission Tomography (PET).
    J Hepatol. 2017 Feb 26. pii: S0168-8278(17)30120.
    PubMed     Text format     Abstract available


  17. KRONES E, Eller K, Pollheimer MJ, Racedo S, et al
    NorUrsodeoxycholic Acid Ameliorates Cholemic Nephropathy in Bile Duct Ligated Mice.
    J Hepatol. 2017 Feb 24. pii: S0168-8278(17)30116.
    PubMed     Text format     Abstract available


  18. MERINO-AZPITARTE M, Lozano E, Perugorria MJ, Esparza-Baquer A, et al
    SOX17 Regulates Cholangiocyte Differentiation and Acts as a Tumor Suppressor in Cholangiocarcinoma.
    J Hepatol. 2017 Feb 22. pii: S0168-8278(17)30114.
    PubMed     Text format     Abstract available


  19. NAKAGAWA R, Muroyama R, Saeki C, Goto K, et al
    miR-425 regulates inflammatory cytokine production in CD4+ T cells via N-Ras upregulation in primary biliary cholangitis.
    J Hepatol. 2017 Feb 9. pii: S0168-8278(17)30066.
    PubMed     Text format     Abstract available


  20. GUPTA K, Li Q, Fan JJ, Fong EL, et al
    Actomyosin Contractility Drives Bile Regurgitation as an Early Response During Obstructive Cholestasis.
    J Hepatol. 2017 Feb 8. pii: S0168-8278(17)30061.
    PubMed     Text format     Abstract available


  21. VESTERHUS M, Holm A, Hov JR, Nygard S, et al
    Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
    J Hepatol. 2017 Feb 1. pii: S0168-8278(17)30052.
    PubMed     Text format     Abstract available


    January 2017
  22. MOEINI A, Sia D, Zhang Z, Camprecios G, et al
    Mixed hepatocellular-cholangiocarcinoma tumors: cholangiolocellular carcinoma is a distinct molecular entity.
    J Hepatol. 2017 Jan 23. pii: S0168-8278(17)30014.
    PubMed     Text format     Abstract available


  23. EKSTEEN B, Heatherington J, Oshiomogo J, Panaccione R, et al
    Retraction notice to: PS124-Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (PSC) in Individuals with Inflammatory Bowel Disease [J Hepatol 64 (2016) S199].
    J Hepatol. 2017;66:254.
    PubMed     Text format    


    December 2016
  24. SCHWINGE D, von Haxthausen F, Quaas A, Carambia A, et al
    Dysfunction of hepatic regulatory T cells in experimental sclerosing cholangitis is related with IL-12 signaling.
    J Hepatol. 2016 Dec 10. pii: S0168-8278(16)30705.
    PubMed     Text format     Abstract available


    November 2016
  25. MONTE MJ, Alonso-Pena M, Briz O, Herraez E, et al
    ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia.
    J Hepatol. 2016 Nov 21. pii: S0168-8278(16)30652.
    PubMed     Text format     Abstract available


  26. LOFFLER MW, Chandran PA, Laske K, Schroeder C, et al
    Erratum to "Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient".
    J Hepatol. 2016 Nov 15. pii: S0168-8278(16)30613.
    PubMed     Text format    


    October 2016
  27. RICKE J, Seidensticker M
    Molecular imaging and liver function assessment by hepatobiliary MRI.
    J Hepatol. 2016 Oct 8. pii: S0168-8278(16)30566.
    PubMed     Text format    


  28. SCHRUMPF E, Kummen M, Valestrand L, Greiner TU, et al
    The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation.
    J Hepatol. 2016 Oct 5. pii: S0168-8278(16)30559.
    PubMed     Text format     Abstract available


  29. FICKERT P
    Bad memories from the gut may cause nightmares for the bile ducts - "Nothing fixes a thing so intensely in the memory as the wish to forget it.": Editorial for: "Gut and liver T cells of common clonal origin are detected in primary sclerosing cholangi
    J Hepatol. 2016 Oct 1. pii: S0168-8278(16)30543.
    PubMed     Text format    


    September 2016
  30. VAQUERO J, Guedj N, Claperon A, Ho-Bouldoires TH, et al
    Epithelial-mesenchymal transition in cholangiocarcinoma: from clinical evidence to regulatory networks.
    J Hepatol. 2016 Sep 26. pii: S0168-8278(16)30537.
    PubMed     Text format     Abstract available


  31. HENRIKSEN EK, Jorgensen KK, Kaveh F, Holm K, et al
    Gut and liver T cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease.
    J Hepatol. 2016 Sep 16. pii: S0168-8278(16)30503.
    PubMed     Text format     Abstract available


  32. RAGGI C, Correnti M, Sica A, Andersen JB, et al
    Cholangiocarcinoma Stem-like Cells Shapes Tumor-initiating Niche by Regulating Associated Macrophages.
    J Hepatol. 2016 Sep 1. pii: S0168-8278(16)30472.
    PubMed     Text format     Abstract available


  33. FUCHS CD, Paumgartner G, Wahlstrom A, Schwabl P, et al
    Metabolic Preconditioning Protects BSEP/ABCB11-/- Mice against Cholestatic Liver Injury.
    J Hepatol. 2016 Sep 1. pii: S0168-8278(16)30482.
    PubMed     Text format     Abstract available


    August 2016
  34. PERUGORRIA MJ, Bujanda L, Banales JM
    More insight into the diversity of cholangiocyte ciliopathies.
    J Hepatol. 2016 Aug 31. pii: S0168-8278(16)30475.
    PubMed     Text format    


    July 2016
  35. GRAMMATIKOPOULOS T, Sambrotta M, Strautnieks S, Foskett P, et al
    Mutations in DCDC2 (doublecortin domain-containing protein 2) in neonatal sclerosing cholangitis.
    J Hepatol. 2016 Jul 25. pii: S0168-8278(16)30342.
    PubMed     Text format     Abstract available


  36. LOFFLER MW, Anoop Chandran P, Laske K, Schroeder C, et al
    Personalized peptide vaccine induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient.
    J Hepatol. 2016 Jul 7. pii: S0168-8278(16)30323.
    PubMed     Text format     Abstract available


    May 2016
  37. VERKADE HJ, Bezerra JA, Davenport M, Schreiber RA, et al
    Biliary atresia and other cholestatic childhood diseases: advances and future challenges.
    J Hepatol. 2016 May 6. pii: S0168-8278(16)30186.
    PubMed     Text format    


    April 2016

  38. EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones.
    J Hepatol. 2016 Apr 11. pii: S0168-8278(16)30032.
    PubMed     Text format    


  39. WESTBROOK RH, Dusheiko G, Williamson C
    Pregnancy and liver disease.
    J Hepatol. 2016;64:933-45.
    PubMed     Text format     Abstract available


    February 2016
  40. HAN Y, Meng F, Venter J, Wu N, et al
    miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.
    J Hepatol. 2016 Feb 23. pii: S0168-8278(16)00157.
    PubMed     Text format     Abstract available


  41. VAN DER WOERD WL, Wichers CG, Vestergaard AL, Andersen JP, et al
    Defective plasma membrane targeting of p.I661T-ATP8B1, associated with familial intrahepatic cholestasis, can be rescued in vitro by CFTR correctors.
    J Hepatol. 2016 Feb 12. pii: S0168-8278(16)00076.
    PubMed     Text format     Abstract available


  42. YOVCHEV MI, Locker J, Oertel M
    Biliary fibrosis drives liver repopulation and phenotype transition of transplanted hepatocytes.
    J Hepatol. 2016 Feb 5. pii: S0168-8278(16)00079.
    PubMed     Text format     Abstract available


    January 2016
  43. EKSTEEN B, Heatherington J, Oshiomogo J, Panaccione R, et al
    RETRACTED: Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (Psc) in Individuals with Inflammatory Bowel Disease.
    J Hepatol. 2016;64.
    PubMed     Text format     Abstract available


    December 2015
  44. JEFFERY HC, van Wilgenburg B, Kurioka A, Parekh K, et al
    Bacteria Exposed Biliary Epithelium and Liver B Cells Activate Intrahepatic Mait Cells in an MR1-Dependent Manner.
    J Hepatol. 2015 Dec 29. pii: S0168-8278(15)00858.
    PubMed     Text format     Abstract available


  45. POUPON R
    ASBT inhibitors in cholangiopathies - good for mice, good for men?
    J Hepatol. 2015 Dec 18. pii: S0168-8278(15)00808.
    PubMed     Text format    


    November 2015
  46. VILGRAIN V, Van Beers BE, Pastor CM
    Insights into the diagnosis of hepatocellular carcinomas with hepatobiliary MRI.
    J Hepatol. 2015 Nov 26. pii: S0168-8278(15)00774.
    PubMed     Text format     Abstract available


    October 2015
  47. BAGHDASARYAN A, Fuchs CD, Osterreicher CH, Lemberger UJ, et al
    Inhibition of Intestinal Bile Acid Absorption Improves Cholestatic Liver and Bile Duct Injury in a Mouse Model of Sclerosing Cholangitis.
    J Hepatol. 2015 Oct 31. pii: S0168-8278(15)00723.
    PubMed     Text format     Abstract available


  48. KO S, Choi TY, Russell JO, So J, et al
    Bromodomain and extraterminal (BET) proteins regulate biliary-driven liver regeneration.
    J Hepatol. 2015 Oct 23. pii: S0168-8278(15)00716.
    PubMed     Text format     Abstract available


  49. ACUNA M, Gonzalez-Hodar L, Amigo L, Castro J, et al
    Transgenic overexpression of Niemann-Pick C2 protein promotes cholesterol gallstone formation in mice.
    J Hepatol. 2015 Oct 7. pii: S0168-8278(15)00669.
    PubMed     Text format     Abstract available


  50. ELFERINK RO, Paulusma CC
    MRP2 in cholestasis: Putting down the anchor.
    J Hepatol. 2015 Oct 1. pii: S0168-8278(15)00666.
    PubMed     Text format    


    September 2015
  51. BEUERS U, Gershwin ME, Gish RG, Invernizzi P, et al
    Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.
    J Hepatol. 2015 Sep 10. pii: S0168-8278(15)00459.
    PubMed     Text format    


    August 2015
  52. DE VRIES AG, Bakker-van Waarde WM, Dassel AC, Losekoot M, et al
    A novel phenotype of a hepatocyte nuclear factor homeobox A (HNF1A) gene mutation, presenting with neonatal cholestasis.
    J Hepatol. 2015 Aug 22. pii: S0168-8278(15)00543.
    PubMed     Text format     Abstract available


  53. KAMATH PS, Poterucha JJ, Ludwig J
    Primary Biliary Cirrhosis by Another Name is Still PBC.
    J Hepatol. 2015 Aug 19. pii: S0168-8278(15)00555.
    PubMed     Text format    


  54. LEE DG, Lee SH, Kim JS, Park J, et al
    Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression.
    J Hepatol. 2015 Aug 17. pii: S0168-8278(15)00548.
    PubMed     Text format     Abstract available


  55. BOSCH A, Dumortier J, Maucort-Boulch D, Scoazec JY, et al
    Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence.
    J Hepatol. 2015 Aug 14. pii: S0168-8278(15)00545.
    PubMed     Text format     Abstract available


  56. LIU HX, Keane R, Sheng L, Wan YY, et al
    Implications of microbiota and bile acid in liver injury and regeneration.
    J Hepatol. 2015 Aug 6. pii: S0168-8278(15)00533.
    PubMed     Text format     Abstract available


    July 2015
  57. CHAI J, Cai SY, Liu X, Lian W, et al
    Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis.
    J Hepatol. 2015 Jul 23. pii: S0168-8278(15)00479.
    PubMed     Text format     Abstract available


  58. MENG F, Alpini G
    Peri-scoping the biliary tree reveals stem cell activation in peribiliary glands in Primary Sclerosing Cholangitis.
    J Hepatol. 2015 Jul 23. pii: S0168-8278(15)00478.
    PubMed     Text format    


  59. RAVIKUMAR R, Tsochatzis E, Jose S, Allison M, et al
    Risk Factors for Recurrent Primary Sclerosing Cholangitis After Liver Transplantation.
    J Hepatol. 2015 Jul 14. pii: S0168-8278(15)00467.
    PubMed     Text format     Abstract available


    June 2015
  60. CARPINO G, Cardinale V, Renzi A, Hov JR, et al
    Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.
    J Hepatol. 2015 Jun 25. pii: S0168-8278(15)00410.
    PubMed     Text format     Abstract available


  61. DE VRIES EM, Verheij J, Hubscher SG, Leeflang MM, et al
    Applicability and Prognostic Value of Histologic Scoring Systems in Primary Sclerosing Cholangitis.
    J Hepatol. 2015 Jun 18. pii: S0168-8278(15)00399.
    PubMed     Text format     Abstract available


    May 2015
  62. OUT C, Patankar JV, Doktorova M, Boesjes M, et al
    Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4.
    J Hepatol. 2015 May 25. pii: S0168-8278(15)00336.
    PubMed     Text format     Abstract available


  63. FARRAR CT, DePeralta DK, Day H, Rietz TA, et al
    3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model.
    J Hepatol. 2015 May 25. pii: S0168-8278(15)00335.
    PubMed     Text format     Abstract available


    November 2014
  64. KOH S, Bertoletti A
    Cancer immunotherapy: targeting the difference.
    J Hepatol. 2014;61:1175-7.
    PubMed     Text format    


    July 2014
  65. VILARINHO S, Zeynep Erson-Omay E, Harmanci AS, Morotti R, et al
    Pediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations.
    J Hepatol. 2014 Jul 9. pii: S0168-8278(14)00471.
    PubMed     Text format     Abstract available


    April 2014
  66. EHLKEN H, Schramm C
    PSC: Novel disease associations providing pathogenetic clues?
    J Hepatol. 2014;60:687-8.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Biliary Tract Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: